Investorideas.com - Cannabis Stock News: Harvest One (TSX-V: HVT; OTCQX: HRVOF) Signs Supply Agreement with the Alberta Gaming, Liquor & Cannabis Commission
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Wednesday, December 4, 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (TSXV: $KHRN.V) (TSXV: $HVT.V) (CSE: $HBOR.C) (CSE: $BHNG.C) (TSXV: $ELXR.V)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (TSXV: $KHRN.V) (TSXV: $HVT.V) (CSE: $HBOR.C) (CSE: $BHNG.C) (TSXV: $ELXR.V)
Delta, Kelowna, BC, December 4, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/12041KHRN-HVT-HBOR-BHNG-ELXR.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
But first, according to a recent study, Cannabis consumers are deeply concerned with the use of chemical pesticides and fertilization and the environmental impact resulting from the cultivation process, and are calling for new product standards to ensure safety, freshness and efficacy, a new study in legalized states shows.
Canivate Growing Systems Ltd. (www.thecanivateway.com), conducted a U.S. nationwide survey of more than 600 cannabis consumers in states where adult cannabis purchase is legal. The survey found consumers overwhelmingly support establishing both environmental standards (79% supporting) and quality certifications (77%) for adult recreational cannabis products.
Respondents indicated that they are willing to pay more for cannabis that is grown in an eco-friendly, organic manner, with 64% of respondents agreeing. But when asked about specific cultivation methods, that support increased dramatically. Consumers strongly favor paying more for cannabis that is:
- grown free from chemical pesticides (92%),
- without chemical fertilizers (88%),
- hasn't been irradiated for pathogens (85%),
- is grown in a low carbon footprint environment (82.5%), and
- cultivated in a manner that conserves water (86%).
"The research suggests that consumers are more sophisticated and discerning in their brand trust than was previously thought," said Troy McCellan, CEO of Canivate. "We believe new approaches to cultivation and testing are needed to preserve trust in this new market. The more educated consumers become, the more they will demand products that are environmentally friendly and certifiably proven to be free of chemical toxins, pathogens and decontamination treatments."
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) welcomes today's announcement from ANVISA, the National Agency for Health Surveillance of Brazil, establishing a legalized environment for the sale and consumption of cannabis for medical use. The new regulations will be published in the coming days on the Federal Official Gazette and enter into law 90 days after that.
In the announcement from ANVISA, a new class of medical cannabis-based products will be prescribed by doctors and sold through pharmacies, enabling patient safe and legal access. The regulatory framework sets a comprehensive procedure for the manufacture and import of these products as well as the requirements for commercialization, prescription, dispensing, monitoring and supervision of cannabis products for medical purposes. The resolution was approved unanimously and is valid for an initial three-year term.
Andres Galofre, Khiron Co-founder and Vice President, Business Development, commented, "We congratulate legislators and the health authority in Brazil for their leadership in establishing a legalized environment for medical cannabis in the country. With a population of over 200 million this will directly benefit the health and wellbeing of a significant number of patients in Brazil and affirms our position as a LatAm leader in a rapidly globalizing cannabis market."
Khiron has a firmly established market-entry strategy for Brazil, with Dormul S.A., its wholly owned subsidiary based in Uruguay giving the Company access to the Brazilian market through the Mercosur Regional Trading Bloc. The Company has initiated pre-clinical medical cannabis studies with the Universidad de la República of Uruguay and Institut Pasteur de Montevideo, providing direct strategic opportunity for 3 million patients for medical cannabis in Uruguay, and a Brazilian market of 3.4 million (New Frontier Data). Further, on November 29th the Company announced it had received authorization from the Colombian Technical Quotas Group ("TQG") for the commercialization of medical use High THC cannabis for domestic and export purposes, including to Brazil, with manufacture to begin in Q1 2020.
Harvest One Cannabis Inc. (TSX-V: HVT) (OTCQX: HRVOF) announced that its wholly-owned subsidiary and Licensed Producer United Greeneries Ltd. has entered into an agreement with Alberta Gaming, Liquor & Cannabis Commission to supply Captain's ChoiceTM and Royal HighTM branded cannabis throughout the province.
"This agreement with Alberta represents our fifth provincial supply agreement providing another distribution channel for our premium cannabis products," said Grant Froese, Chief Executive Officer of Harvest One. "This is an important partnership for Harvest One, as Alberta has the most robust provincial retail network with over 330 store fronts and one of the largest adult-use cannabis sales to date."
Under the terms of the agreement, United Greeneries will initially launch five varieties of Royal HighTM branded cannabis in whole-flower format as well as two varieties of Captain's ChoiceTM branded pre-rolled product for sale across Alberta in licensed cannabis stores. The Company is also working towards listing new product categories such as oils, vapes and topicals, to be made available for sale across the province.
United Greeneries produces curated strains of cannabis at its facility located in Duncan, British Columbia and through its cultivation agreement with Stevens Green in Ontario. United Greeneries' cannabis is consistently regarded as a high quality and sought-after product and is now available in five provinces; Ontario, British Columbia, Alberta, Manitoba and Saskatchewan.
Alberta is home to over 330 licensed cannabis stores fronts which represents the largest number of retail outlets in any province in the country. Harvest One will continue to seek new markets for both existing cannabis flower products as well as new cannabis infused products where regulations allow.
Harborside Inc. (CSE: HBOR), a California-focused, vertically-integrated cannabis enterprise, today announced the Grand Opening of their newest dispensary in Desert Hot Springs, this Saturday. The store is Harborside's first retail location outside of the Bay Area and will also be the first drive-thru dispensary in Southern California. Harborside co-founder Steve DeAngelo, local elected officials and other surprise celebrity guests will officially open the dispensary and drive-thru at a public celebration this Saturday.
The 4,800 square foot facility is strategically located on Interstate 10 between Los Angeles and Coachella and will carry both medical and adult-use products, including Harborside's own KEY line of cannabis products. In addition to its highly anticipated drive-thru, the Desert Hot Springs location will partner with Pure Healing Clinic, offering professional acupuncture, herbal medicine and other wellness services. This latest expansion marks Harborside's fourth retail operation in California.
"Harborside is committed to bringing exceptional cannabis products to our neighboring communities, and is proud to provide the Southern California market with best-in-class service and convenience," said Peter Bilodeau, interim CEO of Harborside. "We are especially pleased to have obtained one of the few drive-thru dispensary licenses in Southern California."
"Harborside decided to come to the Coachella Valley because we like to be where the action is," said co-founder and Chairman Emeritus Steve DeAngelo. "The Valley is growing into a world-class center of both the cannabis industry and cannabis tourism, so it's an ideal location to introduce the legendary Harborside retail model and in-house brands to a wider population. We're also bringing some things that the Valley hasn't seen yet, like our drive-thru, an on-site holistic healing clinic, and the legendary knowledge and compassion of our associates."
Bhang Inc. (CSE: BHNG) (OTCQX: BHNGF), a global cannabis CPG brand company with an extensive, award-winning portfolio of products, announced today that Jamie L. Pearson, Bhang’s Interim President, will assume the role of President & CEO, overseeing day-to-day management and strategic initiatives. Scott Van Rixel has stepped down as CEO.
“I am pleased to announce Jamie’s promotion to both President & CEO of Bhang. Jamie has shown considerable strength in her role as President and her work to develop a vision for Bhang’s future. I am confident that Jamie has the necessary skills to lead Bhang and execute our business objectives,” said Scott Van Rixel.
Bhang has issued a letter to its shareholders from Ms. Pearson, providing commentary on the Company's recent developments and upcoming objectives.
The Company is also proud to announce that Jamie was selected as one of the 2019 High Times Female Top 50. The award honors the 50 most influential women across the cannabis landscape, from activists, executives, and scientists, patients, and politicians. The honorees were selected by the brand’s editorial leadership from a pool of over 7,500 public nominations. High Times further honored Jamie by asking her to give the keynote address entitled ‘Breaking the Glass Ceiling’ to the honorees and approximately 300 people on November 13 at the Beverly Wilshire Hotel in California. A copy of her speech can be found on Bhang’s website HERE along with a copy of the full letter below.
Below are some of the highlights from Pearson’s letter to the shareholders.
“Over the past decade, Bhang has become one of the most-recognized brands in cannabis and central to our thesis is our low CAPEX/OPEX operating platform. We do not need to own multi-million-dollar greenhouses, massive production facilities or extravagant retail operations. Our capital-light business model has enabled us to be quick and nimble and is clearly a differentiator. Bhang’s focus is on being a great CPG company – period. We offer excellent products that consumers want and use top-tier manufacturing and distribution partners to get these products into consumers’ hands.”
“Our approach going forward will be to focus on reducing expenses and increasing revenues across product verticals that fall into our food/beverage, lifestyle, and wellness categories. I am pleased to provide the following update on existing and upcoming Bhang initiatives:”
Pearson also went on to discuss the company’s CBD Domestic & Global Distribution, CBD Brokerage, E-Commerce, Red Ace Organics and their THC Licensing Revenue Streams and Deep Manufacturing/Distribution Relationships in Nevada, Florida, Ohio, Michigan, Illinois and Canada.
Elixxer Ltd. (TSX-V: ELXR) (OTCQB: ELXIF) announced that Global Canna Labs has successfully exported 10 kilograms of medical cannabis from Jamaica into Canada.
This shipment of medical cannabis, the largest of its kind known to date, is a significant step forward in the development of Jamaica’s medical, therapeutic and scientific cannabis industry. The Caribbean Licensing Authority, CLA, has been working diligently on creating a viable export platform. Jamaica’s Minister of Industry, Commerce, Agriculture and Fisheries, the Honorable Audley Shaw applauded the news as he recently presented at the CanEx Investment Summit in Toronto on November 28th.
For further information please refer to: Jamaican Observer, December 4th, 2019:
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
Tuesday, December 3, 2019
Investorideas.com - PURA (OTC: $PURA) and KALY (OTC: $KALY) Announce Landing First Kenyan Coffee Shipment Adding to $8 Million 2020 Beverage Revenue Target
Investorideas.com - PURA (OTC: $PURA) and KALY (OTC: $KALY) Announce Landing First Kenyan Coffee Shipment Adding to $8 Million 2020 Beverage Revenue Target
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $LHS.C) (OTCQX: $LHSIF) (OTCQX: $MRMD) (TSX: $FAF.TO)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $LHS.C) (OTCQX: $LHSIF) (OTCQX: $MRMD) (TSX: $FAF.TO)
Delta, Kelowna, BC, December 3, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/12031LHS-LHSIF-MRMD-FAF.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
But first, Shoppers Drug Mart has expanded its online platform for the sale of medical cannabis to include British Columbia, Nova Scotia, Manitoba, Saskatchewan, New Brunswick, P.E.I., Newfoundland and Labrador. The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals.
According to Statistics Canada, over 1.1 million Canadians use cannabis for medical purposes, but more than 800,000 patients are self-medicating with recreational or illegal cannabis without the guidance of a healthcare professional.i In British Columbia, 18,326 people obtain their medical cannabis through the legal system, but the patient population is likely much larger.ii The high rate of self-medicating is concerning as a 2019 survey found that 76 per cent of medical cannabis patients wrongly believe there are no side effects from combining cannabis with other medications.iii
"Canadians continue to use cannabis for medical purposes but many have been left behind by traditional models. Patients need more convenient access to their medicine with professional oversight and trusted support," said Jeff Leger, President, Shoppers Drug Mart. "We expanded Medical Cannabis by Shoppers™ nationally to provide enhanced service to more patients so they can feel empowered to access medical cannabis through the medical market with the guidance of healthcare professionals."
First launched in Ontario in January 2019 and then in Alberta in April 2019, Medical Cannabis by Shoppers™ provides patients access to a number of products from Canadian licensed producers, shipped directly and discreetly to their doorstep. Additionally, support is available for patients through the Shoppers cannabis care centre – a call center staffed by professionals who offer counselling and support for patients. Under current regulations, pharmacists cannot dispense medical cannabis from a pharmacy.
Patients in British Columbia can now obtain their medical document (authorization from a health care practitioner) directly from shoppersdrugmart.ca/cannabis or bring it to their local Shoppers Drug Mart pharmacy to help process the information. Specialized advisors from the Shoppers cannabis care centre will then contact patients, review their medical history and any contraindications with current medications, and provide support with online registration and strain selection.
Education for pharmacists is supported by the Shoppers Drug Mart Medical Advisory Board, a panel of independent medical experts from across the country who provide guidance and advice on new clinical evidence, and have developed clinical algorithms to help the Shoppers cannabis care Advisors select the correct strain based on the prescriber's recommendation.
For patients who do not have access to a healthcare practitioner, Shoppers can connect patients to a licensed physician or nurse practitioner to assess whether a patient is an ideal candidate for medical cannabis. Shoppers can connect patients to healthcare practitioners through an online telemedicine portal or patients can use the Shoppers Clinic Finder at https://cannabis.shoppersdrugmart.ca/medical-document-info
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it is expanding its product offerings by introducing the G Pen product line of personal, portable devices in all of its dispensaries. G Pen products will be available with Liberty's unique Werc Shop terpene blend.
Grenco Science, the maker of the G Pen Gio, Pro, Connect, Elite and Nova, is a leader in engineering advanced cannabis vaporizers, known for its aesthetics, portability, functionality, and user experience. Grenco Science launched the G Pen in 2012 and was one of the first vaporizer companies to develop a portable device for cannabis concentrates. The G Pen's sleek design and ease of use make it a popular choice among consumers.
"In relationship to our ongoing transformation, Liberty is excited to introduce G Pen's line of world class cannabis vaporizers to our patients who have grown to trust and love the access we offer to the best brands in any category," said Victor Mancebo, Interim Chief Executive Officer of Liberty. "Grenco Science has set the standard for excellence with their user-friendly portable vaporizers."
Chris Folkerts, Founder and CEO Grenco Science said, "Grenco Science is pleased to announce its partnership with Liberty Health Sciences, a leader in Florida's vertically integrated market. We look forward to bringing the G Pen product line to all of Liberty's stores and offering greater accessibility to Florida's medical cannabis consumers."
Liberty's product offerings include eight outstanding quality brands including Liberty Health Sciences, Zentient, Pretty Pistil, Papa's Herb, Mary's Medicinal, PAX, Werc Shop, Lemon and Grass, and is currently working on rolling out nine additional brands, subject to Florida Department of Health approval.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, announced that the Company has entered into an importation and distribution agreement with Astral Health Ltd., the operating subsidiary of the LYPHE Group Ltd to supply its cannabis-based medicinal products to patients in the United Kingdom under the MHRA 'specials' programme.
"We look forward to the opportunity to provide access to our cannabis-based medicinal formulations to a population and medical community that is seeing increased demand for quality evidence-based products, such as our proprietary research-backed formulations. Both the Astral and Avicanna teams are aligned on the long-term vision and more importantly are qualified to provide the medical community in the United Kingdom with safe, effective and superior cannabinoid-based solutions, education and training," stated Aras Azadian, Chief Executive Officer.
Dean Friday, Chief Executive Officer of LYPHE, commented "We are very proud to be partnering with Avicanna in bringing their products to the UK market. Avicanna are market-leaders in terms of product quality, and their research-backed formulations give the company a distinct advantage in the UK market".
Under the Agreement, Avicanna will supply Astral with CBMPs, and both Avicanna and Astral will work together to achieve key strategic milestones in the United Kingdom related to market activation, market access and safety. The parties will also work together to collaborate on medical education programs with a focus on safety, dose guidance and efficacy. The Agreement will allow Avicanna to begin generating revenue from a growing UK market, while providing patients with increased access to the life-changing medicines they require.
It is expected that the CBMPs will be prepared in Colombia using Avicanna's proprietary research-backed formulations, using cannabis extracts from Santa Marta Golden Hemp S.A.S., a subsidiary of Avicanna, and manufactured at the facilities of Avicanna's exclusive Colombian manufacturer, Altea Farmaceutica S.A. using Good Manufacturing Practices (GMP).
MariMed Inc. (OTCQX: MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced that its proprietary, in-house brand, Betty's Eddies™, is among the top-selling sublingual and edible products in a national survey conducted by LeafLink, the leading wholesale platform for cannabis products in the United States.
On November 19, LeafLink released its second-annual LeafLink List, honoring the standout cannabis brands, products, and retailers on its B2B e-commerce marketplace, which processes over $1.4B per year in wholesale cannabis orders. Over 1100 brands were included in the survey. MariMed, Inc. in-house brand Betty's Eddies™, which are gluten-free, vegan, and produced with organically grown fruits and veggies, is the LeafLink Winner for Best Selling Medical Product.
MariMed's family of brands sell in the dispensaries it owns and manages, and on a wholesale basis to retailers in each of the six states it operates. Several recent marketing studies have concluded that infused cannabis products will occupy an increasing share of the overall US cannabis market, which according to the 2019 Marijuana Fact Book, is on pace to exceed 35% growth and $12 billion in sales this year.
Betty's is the most widely distributed product in Maryland, reaching over 70 state dispensaries in less than ten months. New SKUs, including Extra Strength Betty's Eddies™, will launch in Maryland, Rhode Island, Illinois, and Massachusetts in December of 2019.
Ryan Crandall, Chief Product Officer and SVP of Sales at MariMed, Inc., said, "I am thrilled cannabis consumers love the Betty's Eddies brand and products as much as our hardworking team, which is responsible for their quality, custom formulation, and wide availability. Betty's will continue to innovate with new seasonal flavors, limited release small-batch drops, and delicious new Betty's products. The expertise to consistently shape the intended product experience in any state or territory is most important to building consumer trust, brand loyalty, and ultimately revenue growth."
The Branded Product Division at MariMed recently launched Betty's Eddies™ in Rhode Island and plans to launch in MA and Puerto Rico in the next 60 days. MariMed will be opening its Panacea Wellness facility in Massachusetts in mid-December for medical cannabis patients, and recently completed the consolidation of its two managed dispensaries in Illinois.
Bob Fireman, CEO of MariMed, Inc., said, "We are pleased to see the strength of our brands recognized for their significant acceptance and sales growth across multiple markets. Our product division is both innovative and highly responsive to tastes, patient needs, and trends that differ from market to market. As our quality manufacturing capacity and licensing relationships grow, we anticipate MariMed's product family to continue to prosper in a crowded market."
Fire & Flower Holdings Corp. (TSX: FAF), will release its financial and operational results for the third quarter ended November 2, 2019 before financial markets open on December 17, 2019.
Fire & Flower's third quarter fiscal 2019 financial and operational results will be available on SEDAR and on the Company's website at https://fireandflower.com/investor-relations.
Following the release of its third quarter fiscal 2019 financial and operational results, Fire & Flower will host a conference call and webcast with Trevor Fencott, Chief Executive Officer at 8:30 AM Eastern Time on December 17, 2019.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)